{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T02:53:25Z","timestamp":1774061605322,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.vaccine.2024.03.057","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T08:38:45Z","timestamp":1712219925000},"page":"3018-3023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Retrospective study on the health and economic burden of hospitalized patients due to pneumonia and invasive pneumococcal infections in Belgium settings"],"prefix":"10.1016","volume":"42","author":[{"given":"Pirson","family":"Magali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marbaix","family":"Sophie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruyneel","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leclercq","family":"Pol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van","family":"Den Bulcke Julie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brauner","family":"Jonathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.03.057_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jeoa.2019.100209","article-title":"Profile of hospitalised elderly patients in Belgium\u2014Analysis of factors affecting hospital costs","volume":"15","author":"De Foor","year":"2020","journal-title":"The Journal of the Economics of Ageing"},{"key":"10.1016\/j.vaccine.2024.03.057_b0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2807\/1560-7917.ES2014.19.31.20869","article-title":"Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009\u20132011","volume":"19","author":"Verhaegen","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2024.03.057_b0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10096-011-1272-4","article-title":"Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality","volume":"31","author":"Welte","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2024.03.057_b0020","first-page":"7","article-title":"Clinical and financial burden of hospitalised community-acquired pneumonia in patients with selected underlying comorbidities in England. BMJ open","author":"Campling","year":"2020","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.vaccine.2024.03.057_b0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jinf.2016.01.011","article-title":"Declining mortality from adult pneumococcal infections linked to children's vaccination","volume":"72","author":"Grau","year":"2016","journal-title":"J Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2024.03.057_b0030","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1469-0691.2011.03692.x","article-title":"Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes","volume":"18","author":"Cilloniz","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2024.03.057_b0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/1469-0691.12461","article-title":"Pneumococcal infection in adults: burden of disease","volume":"20","author":"Drijkoningen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2024.03.057_b0040","unstructured":"Van Herck K, Braeckman T, Van Damme P, Verhaegen J, Surmont F. Incidence estimate of invasive pneumococcal disease in Belgium in 2009 using the capture-recapture method. European Congress of Clinical Microbiology and Infectious Diseases; 2011; Milan; 2011."},{"key":"10.1016\/j.vaccine.2024.03.057_b0045","unstructured":"Blommaert A, Hanquet G, Willem L, et al. Use of pneumococcal vaccines in the elderly: an economic evaluation. Health Technology Assessment (HTA) Brussels: Belgian Health Care Knowledge Centre (KCE). 2016. KCE Reports 274. D\/2016\/10.273\/79."},{"key":"10.1016\/j.vaccine.2024.03.057_b0050","doi-asserted-by":"crossref","unstructured":"Said MA, Johnson HL, Nonyane BA, Deloria-Knoll M, O'Brien KL; AGEDD Adult Pneumococcal Burden Study Team, Andreo F, Beovic B, Blanco S, Boersma WG, Boulware DR, Butler JC, Carratal\u00e0 J, Chang FY, Charles PG, Diaz AA, Dom\u00ednguez J, Ehara N, Endeman H, Falc\u00f3 V, Falguera M, Fukushima K, Garcia-Vidal C, Genne D, Guchev IA, Gutierrez F, Hernes SS, Hoepelman AI, Hohenthal U, Johansson N, Kolek V, Kozlov RS, Lauderdale TL, Marekovi\u0107 I, Masi\u00e1 M, Matta MA, Mir\u00f3 \u00d2, Murdoch DR, Nuermberger E, Paolini R, Perell\u00f3 R, Snijders D, Ple\u010dko V, Sord\u00e9 R, Str\u00e5lin K, van der Eerden MM, Vila-Corcoles A, Watt JP. Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One. 2013;8(4):e60273. doi: 10.1371\/journal.pone.0060273. Epub 2013 Apr 2. PMID: 23565216; PMCID: PMC3615022.","DOI":"10.1371\/journal.pone.0060273"},{"key":"10.1016\/j.vaccine.2024.03.057_b0055","unstructured":"Superior Health Council. Report 9519: Vaccinatie tegen pneumokokken - kinderen; Vaccination contre le pneumocoque - enfants. November 2018. www.css-hgr.be. Accessed Feb 2022."},{"key":"10.1016\/j.vaccine.2024.03.057_b0060","unstructured":"Superior Health Council. Advisory report 9158: Vaccination of immunocompromised or chronically ill children and\/or adults. September 2019. www.css-hgr.be. Accessed Feb 2022."},{"key":"10.1016\/j.vaccine.2024.03.057_b0065","unstructured":"Superior Health Council. Report 9674: Pneumococcal vaccination adults. September 2022. www.css-hgr.be. Accessed Oct 2022."},{"key":"10.1016\/j.vaccine.2024.03.057_b0070","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1080\/21645515.2020.1763739","article-title":"Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups","volume":"16","author":"Boey","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.03.057_b0075","unstructured":"SPF report 2019 : Blikvanger_Gezondheidszorg_AZ_FR.indd, belgium.be."},{"key":"10.1016\/j.vaccine.2024.03.057_b0080","first-page":"12","article-title":"Un projet pilote d\u2019\u00e9valuation des co\u00fbts par pathologie, le projet PACHA","volume":"78","author":"Pirson","year":"2014","journal-title":"Healthc Exec"},{"key":"10.1016\/j.vaccine.2024.03.057_b0085","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2334-12-134","article-title":"Etiology of community-acquired pneumonia in a populationbased study: link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes","volume":"12","author":"Capelastegui","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2024.03.057_b0090","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1183\/09031936.00168811","article-title":"Community-acquired pneumonia in outpatients: aetiology and outcomes","volume":"40","author":"Cill\u00f3niz","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2024.03.057_b0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1471-2334-12-283","article-title":"Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain)","volume":"12","author":"Sicras-Mainar","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2024.03.057_b0100","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s12879-016-1783-9","article-title":"Hospitalization costs for community acquired pneumonia in dutch elderly: an observational study","volume":"16","author":"Vissink","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.03.057_b0105","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1183\/09031936.00128107","article-title":"Early mortality in patients with community-acquired pneumonia: causes and risk factors","volume":"32","author":"Garcia-Vidal","year":"2008","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.vaccine.2024.03.057_b0110","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/13696998.2022.2090734","article-title":"Hospitalization costs of adult community-acquired pneumonia in England","volume":"25","author":"Campling","year":"2022","journal-title":"J Med Econ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24003633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24003633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T05:54:18Z","timestamp":1725688458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24003633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0264410X24003633"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective study on the health and economic burden of hospitalized patients due to pneumonia and invasive pneumococcal infections in Belgium settings","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}